title: Letter in response to Tashkin et al: Limited generalisability of uplift findings to clinical practice.
authors.affiliation: Medical Research Institute of New Zealand, , Wellington, New Zealand.
authors.forename: Steven
authors.initials: S
authors.lastname: Walker
authors.forename: James
authors.initials: J
authors.lastname: Fingleton
authors.forename: Mark
authors.initials: M
authors.lastname: Weatherall
authors.forename: Richard
authors.initials: R
authors.lastname: Beasley
mesh_terms: D005541:Forced Expiratory Volume / Q000187:drug effects*; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000503:physiopathology*; D012602:Scopolamine Derivatives / Q000008:administration & dosage*
chemical_list: D012602:Scopolamine Derivatives
keywords: COPD Pharmacology